CLRO, US18506U2033

ClearOne stock reports a USD 914,000 Q2 loss

Published on 10/07/2026 at 00:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ClearOne stock traded at USD 4.06 on October 6, 2026, up 2.92 percent during the session. Q2 diluted EPS improved to negative USD 0.34 from negative USD 2.64.

CLRO, US18506U2033, Illustration mit AI erstellt.

ClearOne (ISIN US18506U2033) posted a USD 914,000 net loss in fiscal Q2 2026, compared with a USD 4.572 million loss in the year-earlier quarter, according to Canli Capital in the filing for the period ended June 30, 2026. ClearOne's investor-relations page also identifies the company's merger agreement with Cortigent as a central corporate development announced on July 2, 2026.

Q2 loss narrows sharply

ClearOne's diluted loss per share was USD 0.34 in Q2 2026, down from USD 2.64 in Q2 2025, while the operating loss narrowed to USD 919,000 from USD 1.192 million. The comparison matters because the improvement came alongside a very small operating base, leaving the earnings figure sensitive to one-off items and corporate restructuring.

The six-month net loss stood at USD 1.401 million through June 30, 2026, versus USD 7.406 million in the first half of 2025, according to Canli Capital. For investors, the year-on-year reduction in losses is the clearest operating signal, while the absence of reported revenue in the Q2 statement keeps the turnaround highly dependent on the company's next strategic step.

Merger sets the strategic direction

ClearOne's investor-relations page says the July 2, 2026 agreement involves Cortigent, a wholly owned subsidiary of Vivani Medical, and ClearOne's merger subsidiary. ClearOne describes its business as audio, video and web-conferencing technology, so the transaction places the company's future profile ahead of its shrinking legacy operating base.

Investing.com reported on September 16, 2026, that Vivani expected the pricing and closing of the Cortigent and ClearOne transaction in October 2026. The report said the deal remained subject to customary closing conditions, making execution timing a key variable for the equity story.

Cash remains tightly constrained

At June 30, 2026, ClearOne held USD 75,000 in cash against USD 1.371 million in total liabilities, according to Canli Capital. That balance-sheet contrast gives the merger timetable financial importance beyond the headline transaction itself.

ClearOne stock sits below yearly high

ClearOne stock was trading at USD 4.06 on NASDAQ on October 6, 2026, at 3:17 p.m. ET, up 2.92 percent during the session. The stock's 52-week range was USD 2.71 to USD 16.50, while market capitalization stood at USD 10.8 million and volume reached 91,700 shares.